SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017
May 31, 2017 20:10 pm UTC| Business
NEW YORK, May 31, 2017 -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that...
SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017
May 31, 2017 20:10 pm UTC| Business
NEW YORK, May 31, 2017 -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that...
SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017
May 31, 2017 20:10 pm UTC| Business
NEW YORK, May 31, 2017 -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that...
SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017
May 31, 2017 20:10 pm UTC| Business
NEW YORK, May 31, 2017 -- SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that...
Agios Appoints David Scadden, M.D., to the Board of Directors
May 31, 2017 20:09 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic diseases, today announced the appointment of David Scadden, M.D., to its board of...
Agios Appoints David Scadden, M.D., to the Board of Directors
May 31, 2017 20:09 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic diseases, today announced the appointment of David Scadden, M.D., to its board of...
Agios Appoints David Scadden, M.D., to the Board of Directors
May 31, 2017 20:09 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic diseases, today announced the appointment of David Scadden, M.D., to its board of...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows